Business Segments · Goodwill
Oral Tobacco Products — Goodwill
Altria Group Oral Tobacco Products — Goodwill remained flat by 0.0% to $5.08B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $5.08B to $5.08B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026Apr 30, 2026
Rolls up toGoodwill
How to read this metric
An increase suggests recent acquisitions, while a decrease indicates potential impairment of the segment's long-term value.
Detailed definition
Represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinat...
Peer comparison
Standard across consumer goods companies; peers typically report this as part of segment-level intangible assets.
Metric ID:
mo_segment_oral_tobacco_products_goodwillHistorical Data
13 periods
| Q4 '21 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.08B | $5.08B | $5.08B | $5.08B | $5.08B | $5.08B | $5.08B | $5.08B | $5.08B | $5.08B | $5.08B | $5.08B | $5.08B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | +0.0% | — | — | +0.0% | +0.0% | +0.0% | +0.0% | — | +0.0% | +0.0% | +0.0% | +0.0% |
Range$5.08B – $5.08B
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak12+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Altria Group's oral tobacco products — goodwill?
- Altria Group (MO) reported oral tobacco products — goodwill of $5.08B in Q1 2026.
- How has Altria Group's oral tobacco products — goodwill changed year-over-year?
- Altria Group's oral tobacco products — goodwill decreased by 0.0% year-over-year, from $5.08B to $5.08B.
- What does oral tobacco products — goodwill mean?
- The value of intangible assets like brand reputation acquired through past business purchases in the oral tobacco segment.